INS and Other metabolic disease: Although the majority of metabolic disorders in type 2 diabetes are attributable to impaired secretion and insulin action, contributing to hyperglycemia and the development of insulin resistance, there is much evidence to support the relationship between the development of insulin resistance and endocrine function of adipose tissue [17,18,19].